Viking Therapeutics
Focus: Viking Therapeutics is a San Diego-based biotech focused on metabolic and endocrine disorder therapeutics with a pipeline spanning weight loss, NASH, and rare genetic diseases. The company operates at mid-stage development scale with multiple Phase 2/3 programs.
Profile data last refreshed 1h ago · AI intelligence enriched 2w ago
Open Jobs
14+6 this month
Growing — net +6 jobs in 30d
9 jobs added vs 3 removed. Steady team buildout.
Should You Work at Viking Therapeutics?
AI assessmentViking is a solid mid-stage bet for early-career or specialist roles in metabolic disease, but evaluate funding stability and growth timeline before committing.
Why Work Here
- VK2735 in Phase 3 for weight loss positions you in a high-commercial-interest therapeutic area with significant market tailwinds in metabolic disease.
- Balanced pipeline across weight loss (VK2735), NASH (VK2809), bone health (VK5211), and rare disease (VK0214) offers exposure to diverse mechanism development and clinical execution.
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Clinical Trials (1)
NCT04973657A Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMN
Phase 1Help build intelligence for Viking Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.